Citius Pharmaceuticals Inc (CTXR) 0.6400 $CTXR Citius

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Citius Pharmaceuticals Inc (CTXR) 0.6400 $CTXR

Citius Pharmaceuticals to Present at the 2016 Aegis Growth Conference
PR Newswire - Mon Sep 19, 6:00AM CDT
Citius Pharmaceuticals, Inc. ("Citius" (OTC BB: CTXR), a specialty pharmaceutical company dedicated to developing and commercializing adjunctive cancer care and critical care drug products, announced today that its President and CEO, Myron Holubiak, will present at the 2016 Aegis Growth Conference. The Conference will be held on September 20-22, 2016 at the Encore at Wynn Las Vegas.

Citius Initiates Mino-Lok(TM) Phase 3 Trial
PR Newswire - Tue Sep 13, 6:00AM CDT
Citius Pharmaceuticals, Inc. ("Citius" (OTC BB: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today that it has initiated the pivotal Phase 3 clinical trial Mino-Lok(TM), an antibiotic lock solution used to salvage infected central venous catheters (CVCs) and to treat catheter related bloodstream infections (CRBSIs).
MEDP: 30.44 (-0.13)

Citius Pharmaceuticals, Inc., Initiates Manufacturing of Mino-Lok(TM)
PR Newswire - Thu Sep 08, 6:00AM CDT
Citius Pharmaceuticals, Inc. ("Citius" (OTC QB: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today that it has initiated manufacturing for the company's clinical trial of Mino-Lok (TM), an antibiotic lock solution used to salvage central venous catheters (CVCs) and to treat catheter related bloodstream infections (CRBSIs).

Citius Pharmaceuticals to Present at the Rodman & Renshaw 18th Annual Global Investment Conference
PR Newswire - Wed Sep 07, 9:32AM CDT
Citius Pharmaceuticals, Inc. ("Citius" (OTC QB: CTXR), a specialty pharmaceutical company dedicated to developing and commercializing adjunctive cancer care and critical care drug products, announced today that its Chairman, Len Mazur, will present at the Rodman & Renshaw 18th Annual Global Investment Conference. The Conference will be held on September 11-13, 2016 at the Lotte New York Palace Hotel, New York City.

Citius Announces Completion of In-Depth Interviews on Patient-Reported Outcomes: Signs and Symptoms of Hemorrhoids and Treatments
CNW Group - Tue Aug 23, 12:55PM CDT
Leading Life Sciences Market Research Firm Conducted Patient Interviews

Looking for "Firsts" in Health Care? Check Out Upcoming Catalysts for Citius Pharmaceuticals
PR Newswire - Thu Aug 04, 9:13AM CDT
By Sara Bowman, Senior Staff Writer, Online Media Group, Inc.

Citius Pharmaceuticals Provides Shareholder Update on Recent Achievements
PR Newswire - Mon Aug 01, 6:00AM CDT
Citius Pharmaceuticals, Inc. ("Citius" (OTC BB: CTXR), a specialty pharmaceutical company dedicated to developing and commercializing adjunctive cancer care and critical care drug products, today provided shareholders with an update regarding the company's recent more notable achievements.

OTCQX and OTCQB Companies to Present at 2016 Marcum MicroCap Conference
PR Newswire - Tue May 31, 5:49PM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lineup of OTCQX® Best and OTCQB® Venture Market companies presenting at the Marcum MicroCap Conference, taking place June 1-2nd at the Grand Hyatt New York. The Marcum MicroCap Conference, is dedicated to providing a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community. The Conference will feature presentations by CEOs and CFOs from various industry sectors, expert panels, and the opportunity to meet with management of presenting companies on a one-on-one basis.
LTEA: 4.90 (-0.10)

Citius Pharmaceuticals Announces Results from Phase 2a Trial of Hydrocortisone and Lidocaine Combination Cream in Patients with Grade I and II Hemorrhoids
PR Newswire - Mon Feb 01, 6:00AM CST
Citius Pharmaceuticals, Inc. (OTCQB: CTXR) today announced top line data from the first Phase 2a clinical trial of hydrocortisone acetate (HC) and lidocaine hydrochloride (L) as single agents and in combination (HC+L) in patients with grade I and II hemorrhoids. Citius' hydrocortisone and lidocaine cream is targeting to become the first FDA -approved prescription product to treat hemorrhoids in the U.S.

Citius Pharmaceuticals, Inc. Announces Appointment of Mr. Suren Dutia to Its Board of Directors
PR Newswire - Thu Oct 08, 6:00AM CDT
Citius Pharmaceuticals, Inc. (OTCQB: CTXR), (the "Company" announced today that it has appointed Mr. Suren Dutia to the board of directors effective October 8, 2015.

Citius Pharmaceuticals Announces Myron Holubiak, Former President of Roche Laboratories, Inc., USA, has Joined Its Board of Directors
PR Newswire - Tue Oct 06, 6:00AM CDT
Citius Pharmaceuticals, Inc. (OTCQB: CTXR), (the "Company" announced today that it has appointed Mr. Myron Holubiak to the board of directors effective October 1, 2015.
BIOS: 2.87 (-0.05), ASMB: 7.32 (+0.16)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ALP's Bold NYC Pop-Up: A Gamble or Genius Move?

Updated Category News Views 20

ALP Swings Big in the Big Apple Here's a move that's about as loud as blaring your TV at midnight — ALP, the nicotine pouch brand that’s been taking quiet corners of rural America by storm, is barging into New York City with a brazen pop-up and a parade of marketing antics. Think of it as taking the Wild West and plunking it down in the urban jungle. They're...

Continue Reading
Bimbo Bakeries Teamsters Gear Up for Strike in NJ

Updated Category News Views 73

A Brewing Storm at Bimbo Bakeries The morning air in East Brunswick fills with more than just the scent of fresh bread; there’s a tension you can slice through with a butter knife. Unwavering and fired-up, over 90 workers at Bimbo Bakeries have thrown their hats into the ring, ready to strike to protect something as sacred as the dough they churn—Teamsters' health...

Continue Reading
Skyways Unleashes Skyreach: A Bold Step in Autonomous Cargo

Updated Category News Views 43

Dropping Cargo the New Way No more messing around with runways and cumbersome logistics—Skyways just took a sledgehammer to traditional cargo transport with the launch of its Skyreach platform. This bad boy is a long-range autonomous Vertical Takeoff and Landing (VTOL) aircraft that promises to shake up the defense and commercial sectors. We've got flights kicking off...

Continue Reading
PNU and Cellenkos Team Up for Biotech Advancements

Updated Category News Views 121

Paving New Paths in Biotech Collaboration When a university and a biotech company shake hands to bolster their capabilities in the ever-evolving field of clinical trials and cell and gene therapies, investors and industry buffs alike should perk up. The College of Medicine at Princess Nourah bint Abdulrahman University (PNU) has just inked a Memorandum of Understanding...

Continue Reading
Solidion Technology's Q3 Results: Strong Cash, EPS Growth

Updated Category News Views 20

Solidion Makes Big Waves with Q3 Financial Performance Hot off the press, Solidion Technology, Inc. (NASDAQ: STI) has released its third quarter 2026 financial results, and let me tell you, it's a breath of fresh air for this advanced battery technology player. Maintaining a robust cash position and showcasing a stark contrast in earnings from last year, the company...

Continue Reading
WIN Expands Global Family Support to 124 Countries

Updated Category News Views 55

WIN's Ambitious Global Expansion In the ever-twisting labyrinth of corporate benefits, WIN is stepping up its game. We're talking an expansion that balloons past traditional fertility offerings into a global medley of support services covering every conceivable family and health scenario. It ain’t just about making babies anymore. When you're dealing with 124 countries,...

Continue Reading
O-I Glass Faces Legal Storm Over Misleading Investor Claims

Updated Category News Views 22

Turbulence Hits O-I Glass Stock Another day, another company in hot water—and today, it's O-I Glass, Inc. (NYSE: OI) we're talking about. The company's shares plummeted by 15.01% in one fell swoop on July 29, 2026, right after it dropped its financial bombshell. Let’s break this drama down, shall we? The Legal Brass Tacks Investors who took the bait on O-I Glass...

Continue Reading
Weinberger Law Group Secures Top Tier Family Law Ranking

Updated Category News Views 42

A Testament to Legal Mastery: Weinberger's Latest Accolade In the crowded field of family law, standing out takes more than legal chops. Services have to resonate deeply with the real-life messiness of people's lives. That's what makes Weinberger Divorce & Family Law Group's ranking on the 2027 Best Law Firms® list a real feather in their cap. They're holding down Tier 1...

Continue Reading
Spatial Genomics Market Set for Major Expansion by 2031

Updated Category News Views 86

The Rise of Spatial Genomics You’ve got to hand it to the science behind spatial genomics and transcriptomics—this arena’s not just on a hot streak; it’s scorching. We’re staring down the barrel of a market raring to more than double in value, surging from a worth of USD 0.67 billion in 2026 straight to the big USD 1.23 billion in 2031. The CAGR that’s...

Continue Reading
Strathcona Resources Q3 2026: Dividends, Deals, and Growth

Updated Category News Views 225

Digging into Strathcona's Third Quarter Strathcona Resources (TSX: SCR) is strutting its stuff again, dropping a third-quarter report that reads like a playbook for solid energy sector performance. First off, let’s talk about that dividend bump. The company decided to sprinkle some cheer with a 7% increase in its quarterly dividend, now at $0.32 per share. Not exactly...

Continue Reading

Top 5 Most Recently Viewed Articles

Quantexa Strengthens Advisory Board with Tech and Finance Experts

Updated Category News Views 237

Quantexa Expands Advisory Board with Industry Leaders Quantexa, a leader in Decision Intelligence (DI), has recently appointed two distinguished figures in technology and finance, enhancing its Advisory Board as part of its growth strategy. The company welcomes Steven Guggenheimer and Franck Petitgas to guide its ambition to broaden its global reach and innovate its...

Continue Reading
Key Insider Activity at Matador Resources Sparks Interest

Updated Category News Views 128

Key Insider Activity at Matador Resources Sparks Interest Recently, there was a notable insider purchase at Matador Resources Co (NASDAQ: MTDR) made by William Thomas Elsener, the Executive Vice President of the company. This transaction has stirred the interest of investors and analysts alike, particularly as it entails a purchase of 1,000 shares reported in a SEC...

Continue Reading
Hamilton ETFs Reveals Monthly Cash Distributions for 2025

Updated Category News Views 563

Hamilton ETFs Announces Monthly Cash Distributions Hamilton Capital Partners Inc. (“Hamilton ETFs”) is set to share its monthly cash distributions for the various ETFs listed on the Toronto Stock Exchange. These distributions pertain to the period concluding January 2025, offering investors a reliable income stream. Details of Monthly Distributions The anticipated...

Continue Reading
Effective Risk Management for Cryptocurrency Traders

Updated Category Crypto Views 318

For traders of cryptocurrencies, good risk management is knowing how volatile the market is, establishing reasonable objectives, and diversifying portfolios. Making educated choices is aided by using stop-loss and take-profit orders together with technical analysis tools. Success in trading over the long run depends on psychological risk management, risk management...

Continue Reading
Graitec's AI Vision: Transforming AECO with Three Horizons

Updated Category News Views 30

Graitec's Bold Move with AI in AECO You ever think you'd see the day where AI strides into architecture, engineering, construction, and operations (AECO) like it owns the place? That day is here, and Graitec is not just riding the wave—they're building the surfboard. It's not just about speeding things up; it's making sure there's accountability every step of the way....

Continue Reading